2014
DOI: 10.1016/j.jcyt.2013.12.006
|View full text |Cite
|
Sign up to set email alerts
|

Mesenchymal stromal cell injection protects against oxidative stress in Escherichia coli–induced acute lung injury in mice

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

5
46
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 59 publications
(51 citation statements)
references
References 41 publications
5
46
0
Order By: Relevance
“…LPS group, #vs. LPS+ MSCs group (one-way ANOVA followed by Tukey-Kramer multiple comparisons test; p < 0.05).Where, BM-MSCs; bone marrow mesenchymal stem cells, LPS; lipopolysaccharide, Dex; dexamethasone, NaHCO 3 ; sodium bicarbonate. This data is in line with the finding of Shalaby et al, (2014) who reported an increased survival rate, reduced pulmonary edema and attenuated lung injuries in ALI mice through an increase of anti-oxidant enzyme activities and a decrease of myeloperoxidase activity and malondialdehyde levels in the MSC recipient groups versus the ALI group. These was accompanied by weak +ve inducible nitric oxide synthase immuno-expression in that groups received MSCs tratment.…”
Section: Oxidative Stress Biomarkers In Lung Tissuesupporting
confidence: 92%
“…LPS group, #vs. LPS+ MSCs group (one-way ANOVA followed by Tukey-Kramer multiple comparisons test; p < 0.05).Where, BM-MSCs; bone marrow mesenchymal stem cells, LPS; lipopolysaccharide, Dex; dexamethasone, NaHCO 3 ; sodium bicarbonate. This data is in line with the finding of Shalaby et al, (2014) who reported an increased survival rate, reduced pulmonary edema and attenuated lung injuries in ALI mice through an increase of anti-oxidant enzyme activities and a decrease of myeloperoxidase activity and malondialdehyde levels in the MSC recipient groups versus the ALI group. These was accompanied by weak +ve inducible nitric oxide synthase immuno-expression in that groups received MSCs tratment.…”
Section: Oxidative Stress Biomarkers In Lung Tissuesupporting
confidence: 92%
“…Thus, treatment with CD34þ cells significantly decreased the pulmonary edema and improved the lung wet/dry ratio. Likewise, pulmonary edema is relieved after administration of MSCs derived from bone marrow [4,9] or adipose tissue [35]. We also found that CD34þ cells transplantation reduces hypoxemia at 6 and 24 h after OA challenge.…”
Section: Discussionsupporting
confidence: 53%
“…Harvesting a patient's bone marrow to isolate and culture autologous CD34þ cells cannot be achieved quickly enough to provide emergency treatment for acute disease such as ALI. Therefore, human peripheral blood may be an ideal and practical source for HSCs (such as CD34þ cells and MSCs) because of its accessibility (they do not require invasive bone marrow biopsies), lower risk of viral contamination, immunosuppressive properties and homing to sites of tissue injury [9].…”
Section: Discussionmentioning
confidence: 99%
“…MSCs are capable of selfrenewal and can be obtained from multiple sources, including bone marrow, adipose tissue, umbilical cord blood, skin, tendon, muscle, and dental pulp [6,[12][13][14]. Their relative ease of isolation and enormous expansion potential in culture make them attractive therapeutic candidates [15]. Bone marrow-derived mesenchymal stem cells (BM-MSCs) are one of several types of stem cells, and considerable evidence has demonstrated that BM-MSCs hold promise for the treatment of ALI/ARDS [16][17][18][19].…”
Section: Introductionmentioning
confidence: 99%